Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr. Dimopoulos on BPd Patient-Reported Outcomes in Relapsed/Refractory Myeloma
Optimizing Bispecific Antibodies in Myeloma: Guidance and Future Directions
Dr. Dhakal on the Design of the CARTITUDE-4 Study for Relapsed/Refractory Multiple Myeloma
Dr. Nooka on Incorporating Bispecific Antibodies into the Community Treatment Approach for MM
Proactive Measures to Mitigate Adverse Events from GPRC5D Therapy
Optimizing Bispecific Antibodies in Myeloma: Understanding and Managing Adverse Events
Proactive Strategies for Reducing Adverse Events Associated with GPRC5D Therapy
Management Strategies for Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond
Inside the Academic Approach: Managing Initial Consultations for Bispecific Therapy Referrals
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr. Dimopoulos on BPd Patient-Reported Outcomes in Relapsed/Refractory Myeloma
Optimizing Bispecific Antibodies in Myeloma: Guidance and Future Directions
Dr. Dhakal on the Design of the CARTITUDE-4 Study for Relapsed/Refractory Multiple Myeloma
Dr. Nooka on Incorporating Bispecific Antibodies into the Community Treatment Approach for MM
Proactive Measures to Mitigate Adverse Events from GPRC5D Therapy
Optimizing Bispecific Antibodies in Myeloma: Understanding and Managing Adverse Events
Proactive Strategies for Reducing Adverse Events Associated with GPRC5D Therapy
Management Strategies for Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond
Inside the Academic Approach: Managing Initial Consultations for Bispecific Therapy Referrals
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
